Skip to main content

EagleClaw Capital Managment, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1607636 BOSTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,742,860
+$445,163 QoQ
Shares Held
7,535
+2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#535
of 1,735 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $4,783,467 across 3 Biotechnology names. VRTX ranks #1 (78.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
7,535 $3,742,860

All Filings in VRTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,742,860 7,535
2026-03-31 $3,297,697 7,385
2025-12-31 $3,348,063 7,385
2025-09-30 $2,892,261 7,385
2025-06-30 $3,376,842 7,585
2025-03-31 $3,682,207 7,595
2024-12-31 $3,072,601 7,630
2024-09-30 $3,546,235 7,625
2024-06-30 $3,480,246 7,425
2024-03-31 $3,145,525 7,525
2023-12-31 $3,061,847 7,525
2023-09-30 $2,628,914 7,560
2023-06-30 $2,618,210 7,440
2023-03-31 $2,344,120 7,440
2022-12-31 $2,148,523 7,440
2022-09-30 $2,154,177 7,440
2022-06-30 $2,096,517 7,440
2022-03-31 $1,941,616 7,440
2021-12-31 $1,633,824 7,440